Form 4: GeneDx Holdings Corp. CEO Katherine Stueland Reports Stock Transactions
SEC Form 4
Katherine Stueland, CEO of GeneDx Holdings Corp., reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Summary
- On March 9, 2025, Katherine Stueland, CEO of GeneDx Holdings Corp., acquired 6,546 shares of Class A Common Stock through the vesting of restricted stock units (RSUs) at a price of $0.
- Following this acquisition, Ms. Stueland disposed of 2,731 shares of Class A Common Stock on March 10, 2025, at a weighted average price of $94.7254 per share.
- The sale was to cover tax withholding obligations related to the vesting of the RSUs.
- After these transactions, Ms. Stueland beneficially owns 7,752 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common for executives who receive stock-based compensation. It provides transparency into the trading activities of company insiders.
Comparison to Industry Standards
- Insider transactions are a normal part of executive compensation, particularly in publicly traded companies like GeneDx Holdings Corp.
- Companies like Illumina, Inc. and Myriad Genetics, Inc., which are also in the genetic testing and diagnostics industry, see similar filings from their executives related to stock options and RSU vesting.
- The 'sell to cover' transaction is a standard practice to manage tax obligations associated with equity compensation.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- Shareholders may be interested in insider trading activity as an indicator of management's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 03/09/2023 | Commencement date for RSU vesting, with 6.25% vesting quarterly over four years. |
| 03/09/2025 | Date of RSU vesting and acquisition of 6,546 shares of Class A Common Stock. |
| 03/10/2025 | Date of sale of 2,731 shares of Class A Common Stock to cover tax obligations. |
| 03/11/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.